Antibiotic Treatment for Haemophilus influenzae Infections

Introduction to Antibiotic Choices

The American College of Physicians recommends amoxicillin-clavulanate as the preferred first-line antibiotic for H. influenzae infections, as 18-42% of strains produce β-lactamase, rendering plain amoxicillin or ampicillin ineffective 1, 2, 3

For β-lactamase-negative strains, the Infectious Diseases Society of America suggests amoxicillin 500 mg-1 g PO every 8 hours or ampicillin 500 mg IV every 6 hours 1, 4
For β-lactamase-positive strains or unknown status, the American Academy of Pediatrics recommends amoxicillin-clavulanate 625 mg PO three times daily or 1.2 g IV every 8-12 hours 1, 2, 4
Alternative options for β-lactamase-positive strains include cefuroxime 750 mg-1.5 g IV every 8 hours, ceftriaxone 1-2 g IV once daily, and cefotaxime 1-2 g IV every 6-8 hours 1, 4, 5

When β-lactams cannot be used, the European Respiratory Society suggests levofloxacin 750 mg IV/PO once daily, moxifloxacin 400 mg IV/PO once daily, or ciprofloxacin 400 mg IV every 12 hours 1, 4, 5

The American Thoracic Society recommends clarithromycin 500 mg twice daily as the preferred macrolide when a macrolide is needed, due to its superior activity against H. influenzae compared to azithromycin 2, 6

Doxycycline 100 mg IV/PO every 12 hours is an equally preferred alternative to amoxicillin-clavulanate for non-severe infections, according to the Centers for Disease Control and Prevention 1, 2

For meningitis or severe systemic infections, the Infectious Diseases Society of America recommends ceftriaxone 2 g IV once daily or cefotaxime 2 g IV every 6-8 hours 1, 5
Treatment duration for severe infections is 10-14 days, as suggested by the American College of Physicians 3

The American Academy of Pediatrics advises against using plain ampicillin or amoxicillin empirically without susceptibility testing, due to β-lactamase production rates ranging from 18-42% 1, 2, 3
The Infectious Diseases Society of America warns against assuming all macrolides are equivalent, as clarithromycin has clinically significant superior activity over azithromycin 2, 6

The American Thoracic Society recommends treatment duration of 7 days for non-severe infections and 10-14 days for severe pneumonia or systemic infections 2, 3

If penicillin allergy is present, the European Respiratory Society suggests doxycycline 100 mg twice daily as the first choice, or clarithromycin 500 mg twice daily if tetracycline is contraindicated 2, 3
For severe infections, the Centers for Disease Control and Prevention recommends ceftriaxone or cefotaxime if no history of anaphylaxis to penicillin, or a fluoroquinolone (levofloxacin or moxifloxacin) as an alternative 1, 4, 5

The American Academy of Pediatrics recommends amoxicillin-clavulanate 90 mg/kg/day in 2 doses (maximum 4 g/day) for outpatient treatment of community-acquired pneumonia in children ≥5 years 7
The American Academy of Pediatrics recommends high-dose amoxicillin-clavulanate (90 mg/kg/day amoxicillin component with 6.4 mg/kg/day clavulanate, 14:1 ratio, divided twice daily) for acute otitis media in pediatric patients 8

The Infectious Diseases Society of America recommends ampicillin or penicillin G (if local resistance minimal) for fully immunized children with community-acquired pneumonia (inpatient) 7
The American Academy of Otolaryngology-Head and Neck Surgery recommends amoxicillin-clavulanate 1.75-4 g/250 mg daily (calculated efficacy 90-91% clinical, 97-99% bacteriologic) for mild acute bacterial rhinosinusitis in adults without recent antibiotic use 9

The American Academy of Pediatrics recommends amoxicillin 90 mg/kg/day in 2 doses (outpatient) for children <5 years with pneumonia 7
The American Academy of Pediatrics recommends ampicillin or ceftriaxone/cefotaxime (inpatient) for children <5 years with pneumonia 7